Novivo Healthcare

What Novivo Healthcare does

Novivo Healthcare Limited is a Bangladesh-based animal health pharmaceutical company that manufactures and sells feed additives and therapeutic products for commercial poultry, cattle, goat, and fish producers. The company is headquartered in Dhaka (H-168, Lane-3, New DOHS, Mohakhali) and serves the Bangladesh animal protein sector exclusively, with no geographic expansion beyond South Asia evidenced in the source material.

The product portfolio spans more than 20 SKUs across two principal categories — poultry and cattle — covering antibiotics (florfenicol-based Ad Flor 200 Sol), mycotoxin management solutions (Captox), organic mineral complexes with 77 trace minerals (Vannamin, Nefrofit), multi-enzyme blends with defined activity units (Prozyme, Arrownext PR 100 E), organic acid water treatments (Acidol, Raafes V), anti-coccidials (AD Dicla Sol), electrolytes (Electropak), palatability enhancers (Addarome Vanco), liver protectants (Noviliv), respiratory essential oil formulations (Respofit), fertility supplements (Fertil), and immune-support products (Nuviro, Immofit, Biolecin). Products are formulated for administration via drinking water or feed, with defined dosing protocols and packaging ranging from 100ml bottles to 25kg bags.

The business operates an inquiry-based direct-to-customer model: pricing is not publicly disclosed and every product page routes to a contact form, with sales closed by an in-house field team. A secondary channel exists via trade customers, feed millers, and large animal farms that distribute to end-user farmers. The company is privately held and founder-owned under the leadership of Chairman Sayem Haq and Managing Director Tauheed Hossain, both former Novartis Animal Health executives. No external funding, partnership, M&A, or revenue disclosure has been identified in the available data.

Name

Novivo Healthcare

Legal name

Novivo Healthcare Limited

Website

https://novivo.com.bd

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Novivo Healthcare is a Bangladesh-based animal health company that manufactures and sells feed additives and therapeutic products—including antibiotics, enzymes, organic minerals, mycotoxin binders, and immune boosters—for poultry, cattle, and fish farmers via direct inquiry and trade distributors.

Ownership category

akta.pro rank

Product category

Animal Health Products

NAICS

Other Animal Food Manufacturing (311119), Animal Food Manufacturing (3111), Animal Food Manufacturing (31111)

SIC

Pharmaceutical Preparations (2834), Food And Kindred Products (2000)

akta.pro primary industry

Livestock & Poultry Nutrition (Feed & Premixes) (HLAMAHAD)

akta.pro secondary industries

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO), Antiparasitic & Anticoccidial Feed Additives (Coccidiostats, Anthelmintics) (AFADAKAB), Antimicrobials & Anti-infectives (HLAMAEAE), Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals) (HLAMAEAN)

Keywords

• Animal health products
• Feed additives
• Poultry nutrition
• Veterinary pharmaceuticals
• Livestock supplements

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Animal Health Product Sales: Novivo Healthcare generates revenue through the manufacture and sale of animal health products including pharmaceuticals, nutritional supplements, probiotics, enzymes, and health management solutions for poultry, cattle, goats, and fish. Products are sold in various packaging sizes (100ml, 500ml, 25kg bags, 5kg containers) through direct customer inquiry and engagement.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Novivo Healthcare manufactures and sells pharmaceutical and nutritional products for poultry, cattle, goats, and fish farming in Bangladesh. The portfolio includes antibiotics, probiotics, multi-enzyme blends, mineral supplements, gut acidifiers, anti-coccidials, liver protectors, immune boosters, toxin binders, electrolytes, and feed palatability enhancers formulated for administration via drinking water or feed.

Product overview

Novivo Healthcare is an animal health company offering a comprehensive portfolio of pharmaceutical and nutritional products for poultry, cattle, and livestock farming in Bangladesh. The product portfolio includes antibiotics (Ad Flor 200 Sol), mycotoxin management solutions (Captox, Captox Powder), mineral supplements (Vannamin, Nefrofit, Novical DS), digestive aids (Prozyme, Raafes V), electrolytes (Electropak), water treatments (Acidol), coccidiosis control (AD Dicla Sol), enzymes (Arrownext PR 100 E), palatability enhancers (Addarome Vanco), antiviral/immune support (Nuviro, Immofit), liver protectants (Noviliv), respiratory products (Respofit), and livestock fertility supplements (Fertil). The products target the poultry, cattle, and broader livestock sectors with solutions for growth promotion, disease prevention, and productivity enhancement.

Differentiator

Problem solved

Functional benefit

Products and services

• Captox

Quantifiable outcome

• Reduced mortality rates from respiratory challenges in poultry (10-80% reduction range mentioned)
• +3 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Elanco Animal Health: Global animal health leader that acquired Novartis Animal Health in 2015 — the very business from which Novivo's founders came. Directly comparable as a full-portfolio livestock pharma and feed-additive supplier, though operating at multinational scale.
• Virbac: France-based animal health company covering pharmaceuticals, vaccines, and nutrition for livestock and companion animals. Comparable in product mix spanning anti-infectives, parasiticides, and nutritional supplements for production animals.
• Zoetis: World's largest pure-play animal health company, offering pharmaceuticals, vaccines, and diagnostics across poultry and livestock. Comparable in product breadth and target species, but with vastly greater R&D and global registration capability.

Direct peers

• Ceva Santé Animale: Global veterinary pharmaceutical company with strong poultry and swine focus, including anti-infectives, anti-coccidials, and reproductive products. Closely matches Novivo's therapeutic + species-specific positioning, especially in emerging markets.
• Phibro Animal Health: Animal health and nutrition company specializing in anti-coccidials, antibacterials, and feed additives for poultry and livestock. Most directly comparable competitor in terms of coccidiostat (diclazuril/salinomycin-class) and nutritional product overlap.
• Vetoquinol: Independent global animal health company focused on livestock pharmaceuticals and supplements, with strong emerging-market presence. Comparable mid-sized competitor in anti-infectives, anti-coccidials, and nutritional specialties for poultry and dairy.
• Huvepharma: Bulgarian-headquartered animal health company focused on anti-coccidials, antibacterials, enzymes, and feed additives. Direct overlap with Novivo's anticoccidial, enzyme, and feed-additive portfolio for poultry producers in emerging markets.

Regional players

• Renata Animal Health: Animal health division of Renata Limited, one of Bangladesh's largest pharmaceutical companies. Overlaps with Novivo on veterinary anti-infectives, coccidiostats, and nutritional supplements, and competes for the same feed-mill and integrator customers.
• ACI Animal Health: Bangladesh-based diversified conglomerate (ACI Limited) with a sizable animal health division covering vaccines, pharmaceuticals, and feed additives. Most direct in-country peer sharing the same customer base of Bangladeshi poultry, dairy, and fish farmers.
• Eskayef Pharmaceuticals (animal health): Bangladeshi pharmaceutical manufacturer (Transcom Group) with a growing animal health portfolio covering anti-infectives and nutrition. Comparable as a domestic pharma-grade manufacturer moving into the same poultry and livestock health segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Novivohealthcare
• LinkedInlinkedin.com/company/novivo-healthcare-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novivo Healthcare